MacLean HJ, Freedman MS. Multiple Sclerosis: Following clues from cause to cure. Lancet Neurol 2009;8:6-8.
Mollenhauer B, Locascio JJ, Trenkwalder C, Schlossmacher MG. Cerebrospinal fluid values in patients with alpha-synuclein-linked brain diseases. N Engl J Med 2009; resubmission invited.
Kolaj, M and Renaud, L.P. Metabotropic glutamate receptors in median preoptic neurons modulate neuronal excitability and glutamatergic and GABAergic inputs from the subfornical organ. Journal of Neurophysiology, 103: 1104-1113, 2010.
Multiple Sclerosis Society of Canada, $2,419,701, 2006-2010, Long term outcomes following immunoablative therapy and autologous stem cell transplant for poor prognosis Multiple Sclerosis.
CIHR Operating Grant, $718,615, 2009-2015, Regulating excitability in spinal sympathetic preganglionic neurons: focus on nitric oxide and electrotonic coupling.
CIHR, $1,260,000, 2010-2015, Validation of the lysosomal cathepsin enzymes as targets for brain disorders linked to alpha-synuclein deposition.
The Division of Neurology at Ottawa’s Department of Medicine is pursuing a vision for growth by focusing on three key areas of subspecialty interest: Stroke, Movement Disorders and Multiple Sclerosis. Each specialty area is rooted in a strong dedication and state-of-the-art expertise in the care of our patients, complemented by active multidisciplinary clinical research and closely linked to basic neuroscience research at the University level.  The Division of Neurology has achieved considerable success in research productivity, publications, and grant funding – while keeping a clear focus on our duty to both patients and community. In the past few years, the Division of Neurology has been successful in recruiting several high tier clinician scientists and dedicated clinical teachers.  This has also been an exciting time of consolidation of resources in entirely renovated facilities: neuroscience clinic and office space, clinical teaching unit and stroke clinic.
Clinician investigators in the Division of Neurology combine with basic neuroscientists in the Ottawa Hospital Research Institute and the Faculty of Medicine at the University of Ottawa to form one of the strongest translational research groups in brain research in Canada. Areas of specific strength in clinical research are in multiple sclerosis, Parkinson’s disease and cerebrovascular disease.
The Division of Neurology cherishes its mandate in medical education, in close partnership with the University of Ottawa, at both the undergraduate and graduate levels. Â The residency program has tripled in size over the past 5 years, and has continued to enjoy a perfect record of success at national exams for two decades. Our residents enjoy the atmosphere of collegiality, and our vibrant enthusiasm for learning in a rich clinical and academic environment.
The Division of Neurology has maintained the highest standing in general clinical neurology consultation service in addition to offering a full complement of subspecialty clinics : Stroke, Parkinson’s and Movement Disorders, Multiple Sclerosis, Neuromuscular Diseases, Epilepsy, Memory Disorders. There are affiliated clinical neurophysiology laboratories (EEG, EMG, EP, intensive monitoring) as well as Neurovascular Doppler. We have strong links with well integrated Neuroradiology, Neurosurgery, Neuro-ophthalmology and Neuropsychology divisions. Patients are admitted to the clinical teaching unit, where a strong multidisciplinary care plan has been developed, or to a state of the art Neuro-Observation area.
Learn About Our Clinical Highlights
Neurology inpatient and outpatient services are located mainly at the Civic Campus, with a number of specialty clinics situated at the General Campus.
THE OTTAWA HOSPITAL, CIVIC CAMPUS, 1053 Carling Avenue, Ottawa ON K1Y 4E9
THE OTTAWA HOSPITAL, GENERAL CAMPUS, 501 Smyth Road, Ottawa ONÂ K1H 8L6
For a complete list of neurology clinic locations and contact information, CLICK HERE.